Join Aptyx in this insightful webinar to discuss the use of ePTFE in medical devices which has enormous advantages, but getting it right requires deep expertise. Join us as we explore the benefits, risks, and mitigation strategies, along with innovative processing approaches that unlock its full potential.
During this webinar experts will explore:
- Guidelines for using ePTFE compared to other materials and appropriate clinical applications
- Characteristics and advantages of various types of ePTFE
- Clinical and performance risks and risk mitigation strategies
- Applications of ePTFE in vascular grafts, stent grafts, sutures, and more
- Innovations in delivering low-profile, high-performance devices
- Future market influences and considerations
Date: May 14, 2025
Time: 12:00 -1:00 PM ET
Location: Online
Join us to discover how you can take your medical device innovation to the next level with the power of ePTFE.
Meet The Speakers
Eric Leopold – Senior Vice President, Aptyx
Eric is medtech veteran with more than 35 years of experience, including in-depth knowledge of endovascular and minimally invasive devices. Known for finding smart solutions, he is a named inventor on 30 U.S. patents in multiple applications.
Eric was recently named Senior Vice President of Aptyx after the acquisition of the Charlotte, N.C., facility of Medical Murray, which develops and produces catheter-based interventional products and transcatheter implants.
At Medical Murray, Eric served for more than 10 years as Chief Technology Officer then President. He led the company’s technology and strategic objectives while also supporting the research and development of new complex catheters and transcatheter implants.
Eric’s career has included roles in both development and production. Adept in both areas, he has a track record of helping companies transition from early stage design and development to production at scale.
Previously, Eric was Vice President of R&D at Altura Medical (acquired by Lombard Medical) where he led the design and development of the novel Altura Endograft System for treating AAA. Other key roles include leading the development of the Micrus Endovascular Microcoil System (acquired by Johnson & Johnson) and building production of Gore covered stent graft systems from the ground up.
Eric holds an MBA from the University of California, Berkeley; an MS in Materials Engineering from San Jose State University; and a BS in Biomedical Engineering from the University of Iowa.
Chris Steadham – Vice President of Technology, Aptyx
A versatile medtech professional, Chris has more than 25 years of international cross-functional leadership in Research and Development, Operations, and General Management of Class II and Class III medical devices. He is a named inventor on several U.S. patents for devices including balloon catheters, a stent graft, and an embolic protection device.
Chris was recently named Vice President of Technology for Aptyx after the acquisition of the Charlotte, N.C., facility of Medical Murray, which develops and produces catheter-based interventional products and transcatheter implants. In this role, he will lead the company’s technology and engineering initiatives.
At Medical Murray, Chris served as General Manager and oversaw all operations at the company’s Charlotte, N.C., facility. He has significant experience in complex interventional systems, including previous roles at Bard Peripheral Vascular (acquired by BD) managing several stent graft and delivery system projects, as well as technical responsibilities at Machine Solutions, JH Technologies, and Guidant (now part of Boston Scientific).
Chris has bachelor’s degrees in both Mechanical Engineering and Physics from Vanderbilt University.
Hear From Us
Sign up to receive emails highlighting our upcoming events, early registration savings, and engagement opportunities for the medical technology community.